VBIV
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
VBIV
Delisted
VBIV was delisted on the 7th of August, 2024.
71 hedge funds and large institutions have $74.5M invested in VBI Vaccines, Inc. New Common Stock (Canada) in 2020 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 26 increasing their positions, 19 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
29% less capital invested
Capital invested by funds: $105M → $74.5M (-$30.1M)
Holders
71
Holding in Top 10
–
Calls
$257K
Puts
$17K
Top Buyers
| 1 | +$1.27M | |
| 2 | +$574K | |
| 3 | +$338K | |
| 4 |
Renaissance Technologies
New York
|
+$326K |
| 5 |
Bank of New York Mellon
New York
|
+$297K |
Top Sellers
| 1 | -$1.27M | |
| 2 | -$253K | |
| 3 | -$187K | |
| 4 |
AC
Athanor Capital
New York
|
-$161K |
| 5 |
JPMorgan Chase & Co
New York
|
-$142K |